| Financial Year |
March 31 2023 |
| Monetary Funds |
503,029,618.47 |
| Held-for-trading Financial Assets |
16,003,594.52 |
| Notes Receivable |
104,084,786.15 |
| Accounts Receivable |
571,026,140.70 |
| Advances to Suppliers |
81,553,716.05 |
| Other Receivables |
22,865,497.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
917,285,418.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,376,084.36 |
| Total Current Assets |
2,286,292,361.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
290,287,789.07 |
| Investment Properties |
9,491,883.54 |
| Fixed Assetes |
2,516,760,964.08 |
| Under-construction Projects |
921,397,508.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
453,990,216.03 |
| R&D expenses |
18,693,226.75 |
| Goodwill |
33,591,063.96 |
| Long-Term Deferred and Prepaid Expenses |
3,513,629.12 |
| Deferred Income Tax Assets |
912,711.58 |
| Other Non-Current Assets |
275,384,931.52 |
| Sub-Total of Non-Current Assets |
4,536,324,446.41 |
| Total Assets |
6,822,616,807.58 |
| Short-Term Loans |
961,020,653.54 |
| Trading Financial liabilities |
566,084.84 |
| Notes Payable |
274,595,450.57 |
| Accounts Payable |
741,223,784.75 |
| Accounts Received In Advance |
101,250.00 |
| Employee Compensation Payable |
66,504,026.20 |
| Taxes Payable |
12,571,083.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
86,463,418.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,080,000.00 |
| Other Current Liabilities |
138,882,038.09 |
| Sub-Total of Current Liabilities |
2,595,776,568.86 |
| Long-term Loans |
369,880,000.00 |
| Bonds Payable |
844,064,220.15 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,349,150.59 |
| Deferred Income Tax Liabilities |
62,111,708.85 |
| Other Non-Current Liabilities |
7,924,473.62 |
| Sub-Total of Non-Current Liabilities |
1,325,881,406.25 |
| Total Liabilities |
3,921,657,975.11 |
| Paid-In Capital(Or Share Stock) |
372,567,844.00 |
| Capital Surplus |
850,089,585.19 |
| Surplus Reserve |
152,138,530.19 |
| LESS:Treasury Stock |
24,805,136.22 |
| Undistributed Profits |
1,338,211,753.91 |
| Minority Stockholder's Interest |
41,659,842.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,859,298,990.12 |
| Owner's Equity（Stockholder's Equity） |
2,900,958,832.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,822,616,807.58 |
